Clinical trial NCT01193829 (Development of Circulating Tumor Cell Molecular Diagnostics Using a Novel Microfluidic Device) aimed at comparing EGFR mutations in primary NSCLC tumors of respective CTCs isolated via a label-free microfluidic device. The gene discussed is EGFR; the disease is neoplasm.